Kintu K, Malaba T, Nakibuka J, et al. RCT of Dolutegravir vs Efavirenz-based therapy initiated in late pregnancy: DOLPHIN-2. CROI 2019, abstract 40-LB.
Remdesivir bij COVID-19: eindresultaten van de WHO Solidarity-studie
aug 2022 | Pneumonie, Virale infecties